Orca Bio

@OrcaBio

Transforming allogeneic cell therapy for patients with blood cancer and autoimmune diseases

Menlo Park, CA

Orca Bio
@OrcaBio
Oct 30
Every light at Light The Night represents a patient, survivor, caregiver, or loved one impacted by blood cancer. We were proud to join @BloodCancerUtd's Light The Night Sacramento to honor those affected by blood cancer and recognize the continued need for better treatment
Orca Bio
@OrcaBio
Oct 25
Today is #MDSAwarenessDay, a time to recognize patients, families and caregivers impacted by myelodysplastic syndrome (MDS). According to @MDSFoundation, an average 33-55 people are diagnosed with MDS every day in the U.S., underscoring the continued need for effective
Orca Bio
@OrcaBio
Oct 23
An inspiring evening with the blood cancer community. We were proud to join @BloodCancerUtd's Light The Night Silicon Valley to honor patients, survivors, caregivers and families affected by blood cancer. Events like these remind us why our work matters and reinforce our
Orca Bio
@OrcaBio
Oct 13
As we continue progressing our pipeline of high-precision cell therapies, we have several openings across commercial, manufacturing, operations and other functions from entry-level to leadership. Interested in a role? Check out our Careers page: orcabio.com/culture-career…
Orca Bio
@OrcaBio
Oct 8
ICYMI: @ASTCT_Journal recently published data highlighting long-term overall survival outcomes associated with our FDA-approved high-precision cell therapy for allogeneic transplant in people with hematologic malignancies. The three-year findings provide important insight into